Maverick Capital’s Merck MRK Stock Holding History

Maverick Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,389	Closed	-$915K	–	503
2023 Q4	$915K	Sell	8,389 -5,462	-39%	-$567K	0.02%	134
2023 Q3	$1.43M	Buy	13,851 +8,349	+152%	+$900K	0.03%	97
2023 Q2	$635K	Buy	+5,502	New	+$625K	0.01%	201
2023 Q1	–	Sell	-1,972	Closed	-$219K	–	516
2022 Q4	$219K	Sell	1,972 -647	-25%	-$66.1K	0.01%	358
2022 Q3	$226K	Buy	+2,619	New	+$234K	0.01%	297
2021 Q4	–	Sell	-1,008	Closed	-$76K	–	522
2021 Q3	$76K	Sell	1,008 -4,472	-82%	-$340K	﹤0.01%	603
2021 Q2	$426K	Sell	5,480 -28,418	-84%	-$2.11M	﹤0.01%	401
2021 Q1	$2.49M	Sell	33,898 -28,189	-45%	-$2.08M	0.02%	134
2020 Q4	$4.85M	Buy	62,087 +38,370	+162%	+$2.93M	0.08%	66
2020 Q3	$1.88M	Sell	23,717 -1,377	-5%	-$108K	0.03%	152
2020 Q2	$1.85M	Buy	25,094 +24,833	+9,515%	+$1.87M	0.04%	187
2020 Q1	$19K	Buy	+261	New	+$20.5K	﹤0.01%	462
2019 Q4	–	Sell	-15,645	Closed	-$1.26M	–	395
2019 Q3	$1.26M	Buy	+15,645	New	+$1.25M	0.02%	253

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Maverick Capital's MRK Position: Q1 2024 in Review

Maverick Capital sold out of Merck (MRK) in Q1 2024, closing a stake of 8,389 shares — an estimated $915K sold.

Maverick Capital first reported a position in MRK in Q3 2019 and held it in 13 quarters. The position peaked at $4.85M in Q4 2020. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

Maverick Capital reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
Maverick Capital sold 8,389 Merck shares in Q1 2024, an estimated $915K.
Maverick Capital first reported a position in Merck in Q3 2019 and held it in 13 quarters.
Maverick Capital's Merck position peaked at $4.85M in Q4 2020.
3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Maverick Capital's 13F filing for Q1 2024, filed 15 May 2024.